PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 01, 2016
- Source ID
- 10.1016/j.ygyno.2016.03.008
Entities
People
- Brad H Nelson
- David R. Kroeger
- John R. Webb
- Katy Milne
Organizations
- BC Cancer Agency
- BC Cancer Foundation
- Canadian Cancer Society Research Institute
- Canadian Institutes of Health Research
- United States Department of Defense